Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Cardurion Pharmaceuticals, Inc.
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
May 11, 2024
From
Cardurion Pharmaceuticals, Inc.
Via
Business Wire
Cardurion Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 05, 2024
From
Cardurion Pharmaceuticals, Inc.
Via
Business Wire
Cardurion Pharmaceuticals to Provide Update on CaMKII Inhibitor Program at the American Heart Association’s Scientific Sessions 2023
November 07, 2023
From
Cardurion Pharmaceuticals, Inc.
Via
Business Wire
Cardurion Pharmaceuticals Welcomes Emma Reeve as Independent Board Director and Audit Chair
October 04, 2023
From
Cardurion Pharmaceuticals, Inc.
Via
Business Wire
Cardurion Pharmaceuticals Strengthens Leadership Team with Appointment of Elizabeth Radcliffe as Chief Financial Officer
January 19, 2023
From
Cardurion Pharmaceuticals, Inc.
Via
Business Wire
Cardurion Pharmaceuticals Announces Dosing of Patients in CARDINAL-HF, a Phase 2 Clinical Trial of its PDE9 inhibitor in Heart Failure
July 19, 2022
From
Cardurion Pharmaceuticals, Inc.
Via
Business Wire
Cardurion Pharmaceuticals Enhances Leadership Team with Appointment of Marcia Moore as Chief Operating Officer
February 16, 2022
From
Cardurion Pharmaceuticals, Inc.
Via
Business Wire
Cardurion Pharmaceuticals Announces Investment of up to $300 Million From Bain Capital
October 27, 2021
From
Cardurion Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.